Saturday 17 October 2026 Export CLSDQ’s income statement to Excel — free account

Clearside Biomedical, Inc.

Clearside Biomedical, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $1.7 million, down 79.8% from fiscal 2023. In the quarter to September 2025, revenue fell 80.6%, EPS grew 24.0% and free cash flow grew 8.15%, each against the same quarter a year earlier.

0.25 0.00 0.00%

Follow CLSDQ

Alert me

Market cap: $2.2M
P/E: 0.0×
Fwd P/E: −0.1×
Dividend yield: —
F-score: 3/9
Altman Z: −22.08
Beneish M: −1.63
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Sep '25	Jun '25	Mar '25	Dec '24	Older periods
ROE Full definition →	58.59%	71.96%	91.00%	125.45%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	2	2	2	4
ROA Full definition →	(127.43%)	(112.50%)	(103.03%)	(116.16%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(307.11%)	(234.80%)	(218.51%)	(174.33%)
Average Days of Receivables Full definition →	29.16	71.49	149.14	111.21
Free Cash Flow per Share Full definition →	(4.15)	(4.28)	(4.60)	(5.22)
Free Cash Flow Full definition →	(21.75)	(22.23)	(23.61)	(25.67)
Capital Expenditures Full definition →	(0.45)	(0.51)	(0.93)	(0.98)
Other line items
Cash ROIC Full definition →	46.12%	56.49%	73.12%	136.32%
Accounts Receivable Turnover Full definition →	6.32	6.49	3.11	4.37
Accounts Payable Turnover Full definition →	0.00	0.00	0.37	0.00
Inventory Turnover Full definition →	—	—	0.00	—
Average Days of Payables Full definition →	0.00	0.00	1,158.56	0.00
Days of Inventory on Hand Full definition →	—	—	0.00	—
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	397.24%	346.11%	463.28%	1,117.19%
Selling, General and Administrative Expense of Revenue Full definition →	380.59%	268.99%	313.68%	709.56%
Share Based Compensation of Revenue Full definition →	99.94%	89.92%	110.84%	271.21%
Operating CF/Net income Full definition →	0.82	0.78	0.74	0.72
Depreciation/Fixed assets Full definition →	0.09	0.03	(0.02)	(0.03)
Capex/Depreciation Full definition →	(1.62)	(5.44)	16.59	8.65
Revenue per Share Full definition →	0.64	0.80	0.73	0.34
Operating CF per Share Full definition →	(4.07)	(4.18)	(4.42)	(5.02)
Capex per Share Full definition →	(0.09)	(0.10)	(0.18)	(0.20)
Capex to Sales Full definition →	0.14	0.12	0.25	0.59

Show all line items

Columns are period end dates

Stockrow Weekly